ADVERTISEMENT
ADVERTISEMENT

Cancer Therapy

Edited by : Neeraja Sankaran C. Fleming, J.H. Wasson, P. Albertsen, M.J. Barry, J. E. Wennberg, "A decision analysis of alternative treatment strategies for clinically localized prostate cancer," Journal of the American Medical Association, 269:2650-8, 1993. (Cited in 88 publications through January 1995) Comments by Craig Fleming, HealthOutcomes Associates, Vancouver, Wash. This evaluation of the relative efficacy of therapies for localized prostate cancer is part of a multi-institutional st

The Scientist Staff

Edited by : Neeraja Sankaran
C. Fleming, J.H. Wasson, P. Albertsen, M.J. Barry, J. E. Wennberg, "A decision analysis of alternative treatment strategies for clinically localized prostate cancer," Journal of the American Medical Association, 269:2650-8, 1993. (Cited in 88 publications through January 1995)

Comments by Craig Fleming, HealthOutcomes Associates, Vancouver, Wash.

This evaluation of the relative efficacy of therapies for localized prostate cancer is part of a multi-institutional study by the Prostate Patient Outcomes Research Team (Prostate PORT) at Dartmouth College Medical School and Harvard Medical School. "The paper has received so much attention because it raises some very controversial issues regarding present treatments for prostate cancer," declares Craig Fleming, a former assistant professor of medicine at Dartmouth and currently president of Health Outcomes Associates in Vancouver, Wash.

"Prostate cancer is one of the most common cancers among men in this country, and currently 35,000 men die each...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
ADVERTISEMENT